B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy

Abstract

Defects in the apoptosis mechanism stimulate cancer cell growth and survival. B cell lymphoma 2 (Bcl-2) is an anti-apoptotic molecule that plays a central role in apoptosis. Bcl-2 is the founding constituent of the Bcl-2 protein family of apoptosis controllers, the primary apoptosis regulators linked with cancer. Bcl-2 has been identified as being over-expressed in several cancers. Bcl-2 is induced by protein kinases and several signaling molecules which stimulate cancer development. Identifying the important function played by Bcl-2 in cancer progression and development, and treatment made it a target related to therapy for multiple cancers. Among the various strategies that have been proposed to block Bcl-2, BH3-mimetics have appeared as a novel group of compounds thanks to their favorable effects on many cancers within several clinical settings. Because of the fundamental function of Bcl-2 in the regulation of apoptosis, the Bcl-2 protein is a potent target for the development of novel anti-tumor treatments. Bcl-2 inhibitors have been used against several cancers and provide a pre-clinical platform for testing novel therapeutic drugs. Clinical trials of multiple investigational agents targeting Bcl-2 are ongoing. This review discusses the role of Bcl-2 in cancer development; it could be exploited as a potential target for developing novel therapeutic strategies to combat various types of cancers. We further highlight the therapeutic activity of Bcl-2 inhibitors and their implications for the therapeutic management of cancer.

Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases

“…Hence, more than 90% of oral cancers are OSCC (151)(152)(153). Proand anti-apoptotic Bcl-2 proteins are involved in oral cancer (154)(155)(156). The migration rate of OSCC may be drastically blocked via the biological action of CA (157).…”

Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights

“…Ursolic acid, majorly extracted from medicinal plants Mimusopscaffra , Ilex paraguarieni, and Glechoma hederacea , show anti-inflammatory, anti-bacterial, anti-oxidant, anti-cancer, and anti-diabetic potential. Still, its bioavailability and solubility limit its clinical application [76] , [79] , [80] , [156] , [157] , [158] , [159] .…”

Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future

“…CA induces apoptosis through inhibiting Bcl-2 action, resulting in the liberation of cyt- c and the consequent activation of caspase-3, representing the fact that CA stimulates apoptosis by the intrinsic apoptotic pathway ( Chang et al, 2010 ; Alam et al, 2019 ; Alam et al, 2021b ). Their anti-oxidant results are arbitrated through modulating pathways, including MAPK, NF-κB, and Akt.…”